Alcon posted decent Q1 results driven by a strong performance in Surgical – the recovery in elective surgeries bolstered growth for consumables. However, Vision Care was weak as the previous year’s panic stocking played spoilsport. Seasonally weak Q2 is expected to be soft and the group’s H2 21 recovery largely hinges upon an improvement in the pandemic situation. Profitability could also come under pressure for the remainder of the year due to additional promotion efforts and the creation of a ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Still not fully out of the woods
Alcon posted decent Q1 results driven by a strong performance in Surgical – the recovery in elective surgeries bolstered growth for consumables. However, Vision Care was weak as the previous year’s panic stocking played spoilsport. Seasonally weak Q2 is expected to be soft and the group’s H2 21 recovery largely hinges upon an improvement in the pandemic situation. Profitability could also come under pressure for the remainder of the year due to additional promotion efforts and the creation of a ....